Indeed, simultaneous blockade of DLL4 and VEGF by bispecific antibodies HD105 and HB32 showed potent anti-tumor and anti-angiogenic activity in vivo and in vitro [233,234]. This evidence concerns the gene DLL4 and neoplasm.